Evidence map›Paper›PMID 31906221›Full record

ArticleCancers2019

Isobolographic Analysis Demonstrates the Additive and Synergistic Effects of Gemcitabine Combined with Fucoidan in Uterine Sarcomas and Carcinosarcoma Cells.

Marcin Bobiński, Karolina Okła, Jarogniew Łuszczki, Wiesława Bednarek, Anna Wawruszak, Gema Moreno-Bueno, Magdalena Dmoszyńska-Graniczka, Rafał Tarkowski, Jan Kotarski

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Marcin BobińskiI Chair and Department of Gynaecological Oncology and Gynaecology, Medical University of Lublin, 20-081 Lublin, Poland.
Karolina OkłaI Chair and Department of Gynaecological Oncology and Gynaecology, Medical University of Lublin, 20-081 Lublin, Poland.
Jarogniew ŁuszczkiI Chair and Department of Pathophisiology, Medical University of Lublin, 20-081 Lublin, Poland.
Wiesława BednarekI Chair and Department of Gynaecological Oncology and Gynaecology, Medical University of Lublin, 20-081 Lublin, Poland.
Anna WawruszakChair and Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-081, Lublin Poland.
Gema Moreno-BuenoLaboratorio de Investigación Traslacional, MD Anderson Cancer Centre Madrid, Calle de Arturo Soria, 270 28033 Madrid, Spain.
Magdalena Dmoszyńska-GraniczkaChair and Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-081, Lublin Poland.ORCID 0000-0002-6248-0930
Rafał TarkowskiI Chair and Department of Gynaecological Oncology and Gynaecology, Medical University of Lublin, 20-081 Lublin, Poland.
Jan KotarskiI Chair and Department of Gynaecological Oncology and Gynaecology, Medical University of Lublin, 20-081 Lublin, Poland.
Medical University of Lublin · PLMD Anderson Cancer Center Madrid · ES

Funding

Medical University of Lublin DS 120Medical University of Lublin DS 121Medical University of Lublin MNmd129
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

fucoidangemcitabineisobolographyuterine sarcoma

Identifiers

PMID31906221
PMCPMC7017062
OpenAlexW2997488028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.